antineoplastic agents

Preferred Label : antineoplastic agents;

MeSH definition : Substances that inhibit or prevent the proliferation of NEOPLASMS.;

MeSH synonym : drugs, antitumor; agents, antitumor; agents, antineoplastic; antineoplastics; antitumor agents; antineoplastic drugs; antitumor drugs; drugs, antineoplastic; chemotherapeutic anticancer drug; drug, chemotherapeutic anticancer; cancer chemotherapy agents; agents, cancer chemotherapy; chemotherapy agents, cancer; cancer chemotherapy drugs; chemotherapy drugs, cancer; drugs, cancer chemotherapy; chemotherapeutic anticancer agents; agents, chemotherapeutic anticancer; anticancer agents; agents, anticancer; Antineoplastic Agent; Agent, Antineoplastic; Anticancer Agent; Agent, Anticancer; Antineoplastic Drug; Drug, Antineoplastic; Antineoplastic; Antitumor Drug; Drug, Antitumor; Cancer Chemotherapy Agent; Agent, Cancer Chemotherapy; Chemotherapy Agent, Cancer; Cancer Chemotherapy Drug; Chemotherapy Drug, Cancer; Drug, Cancer Chemotherapy; Antitumor Agent; Agent, Antitumor;

MeSH annotation : /admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1 ;

Wikipedia link : https://en.wikipedia.org/wiki/Antineoplastic agents;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000970;

UMLS CUI

C0003392;

ATC code(s)
- aflibercept [ATC Code]
- platinum compounds [ATC Code]
- porfimer sodium [ATC Code]
ATC code(s)
- Hedgehog pathway inhibitors [ATC Code]
- Janus-associated kinase (JAK) inhibitors [ATC Code]
- Mammalian target of rapamycin (mTOR) kinase inhibitors [ATC Code]
- Retinoids for cancer treatment [ATC Code]
- alitretinoin [ATC Code]
- amrubicin [ATC Code]
- anti-androgens [ATC Code]
- antineoplastic agents [ATC Code]
- antineoplastic and immunomodulating agents [ATC Code]
- arsenic trioxide [ATC Code]
- bevacizumab [ATC Code]
- calcium folinate [ATC Code]
- celecoxib [ATC Code]
- cisplatin [ATC Code]
- cladribine [ATC Code]
- combinations of antineoplastic agents [ATC Code]
- eflornithine [ATC Code]
- everolimus [ATC Code]
- fluorouracil, combinations [ATC Code]
- flutamide [ATC Code]
- methotrexate [ATC Code]
- nilutamide [ATC Code]
- nitrogen mustard analogues [ATC Code]
- omacetaxine mepesuccinate [ATC Code]
- other antineoplastic agents [ATC Code]
- other antineoplastic agents [ATC Code]
- other plant alkaloids and natural products [ATC Code]
- paclitaxel poliglumex [ATC Code]
- panitumumab [ATC Code]
- platinum compounds [ATC Code]
- polyestradiol phosphate [ATC Code]
- ridaforolimus [ATC Code]
- sirolimus [ATC Code]
- sodium folinate [ATC Code]
- taxanes [ATC Code]
- tegafur, combinations [ATC Code]
- temsirolimus [ATC Code]
- trabectedin [ATC Code]
- tretinoin [ATC Code]
- vinca alkaloids and analogues [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Anticancer agents [ICHI extension code]
- Antineoplastic Antibody-Drug Conjugate [NCIt concept]
- Antineoplastic agents [PASCAL theme]
- Antineoplastic agents [ICD-11 Extension code]
- Antineoplastic antibiotic (substance) [SNOMED CT concept]
- Antitumor [NCIt concept]
- Other antineoplastic drugs [ICD-10 Sub-category (who)]
- other antineoplastic agents [ATC Code]
- other antineoplastic agents [ATC Code]
CISMeF manual mappings
- Antineoplastic agent (substance) [SNOMED CT concept]
- Antineoplastic poisoning (disorder) [SNOMED CT concept]
False automatic mappings
- Medicinal product acting as analeptic agent (product) [SNOMED CT concept]
Indexing information
- ((cis-Pt(NH(3))(2))(2)(mu-OH)(mu-pyrazolate))(2+) [MeSH Supplementary Concept]
- (1-(chloromethyl)-1,2-dihydropyrrolo(3,2-e)indol-3(6H)-yl)(5-fluoro-1H-indol-2-yl)methanone [MeSH Supplementary Concept]
- (1-(chloromethyl)-1,2-dihydropyrrolo(3,2-e)indol-3(6H)-yl)(5-methoxy-1H-indol-2-yl)methanone [MeSH Supplementary Concept]
- (10)-shogaol [MeSH Supplementary Concept]
- (2S,5S,7S)-3alpha-hydroxylexogonic acid [MeSH Supplementary Concept]
- (4-hydroxypyridine)(ammine)dichloroplatinum(II) [MeSH Supplementary Concept]
- (5-chloro-1H-indol-2-yl)(1-(chloromethyl)-1,2-dihydropyrrolo(3,2-e)indol-3(6H)-yl)methanone [MeSH Supplementary Concept]
- (6-amino-1-methyl-5-nitrosouracilato-N3)triphenylphosphinegold(I) [MeSH Supplementary Concept]
- (64)Cu-DOTA-vMIP-II [MeSH Supplementary Concept]
- (8)-shogaol [MeSH Supplementary Concept]
- (Cu(4,4'-dimethyl-2,2'-bipyridine)(glycinato)(H2O))NO3 [MeSH Supplementary Concept]
- (Cu(4,7-dimethyl-1,10-phenanthroline)(acetylacetonato)(H2O))NO3 [MeSH Supplementary Concept]
- (E)-3-(hydroxy(4-nitrophenyl)methyl)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one [MeSH Supplementary Concept]
- (E)-3-(hydroxy(phenyl)methyl)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one [MeSH Supplementary Concept]
- (E)-3-(hydroxy(thiophen-2-yl)methyl)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one [MeSH Supplementary Concept]
- (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl9tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-91,1'-biphenyl0-3-carboxamide [MeSH Supplementary Concept]
- (Pt(II)(DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)) [MeSH Supplementary Concept]
- (PtCl(2)(CH(3)COO)(2)-(NH(3))(1-adamantylamine)) [MeSH Supplementary Concept]
- (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide [MeSH Supplementary Concept]
- (mu4-oxo)tetra-mu4-acetate(4-hydroxy-3,5-bis(morpholinomethyl))tetracopper(II) [MeSH Supplementary Concept]
- 1,3,4-oxadiazole [MeSH Supplementary Concept]
- 1,3,4-tri-O-galloyl-6-O-caffeoyl-beta-D-glucopyranose [MeSH Supplementary Concept]
- 1,4-O-diferuloylsecoisolariciresinol [MeSH Supplementary Concept]
- 1,7-bis(3-methoxy-4-(3-(4-methylpiperazinyl-1-yl)propoxy)phenyl)-4,4-dibenzylheptane-3,5-dione [MeSH Supplementary Concept]
- 1-((2-di-p-tolylbismuthanophenyl)diazenyl)pyrrolidine [MeSH Supplementary Concept]
- 1-(2,3-dichloro-4-((3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methoxy)phenyl)-2-methylenebutan-1-one [MeSH Supplementary Concept]
- 1-(2,3-dichloro-4-((3-phenyl-1,2,4-oxadiazol-5-yl)methoxy)phenyl)-2-methylenebutan-1-one [MeSH Supplementary Concept]
- 1-(2-(1-(2-aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-1,3-benzodiazol-6-yl)ethynyl)cyclohexan-1-ol [MeSH Supplementary Concept]
- 1-(2-(2-methoxyphenylamino)ethylamino)-3-(naphthalene-1-yloxy)propan-2-ol [MeSH Supplementary Concept]
- 1-(3,4,5-trihydroxyphenyl)nonan-1-one [MeSH Supplementary Concept]
- 1-(4-fluoro-3-methoxybenzyl)-N-(9-chloro-3,4-dihydro-2H-1,5-benzodioxepin-7-ylmethyl)-N-isobutylpyrrolidine-3-carboxamide [MeSH Supplementary Concept]
- 1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-enyl-3-(3-(trifluoromethyl)phenyl)acrylate [MeSH Supplementary Concept]
- 1-(6-methoxy-2H-chromen-3-yl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one [MeSH Supplementary Concept]
- 1-(benzofuran-2-yl(phenyl)methyl)-3-(2-(naphthalen-2-yl)-2-oxoethyl)-1H-benzo(d)imidazol-3-ium [MeSH Supplementary Concept]
- 1-O-hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol [MeSH Supplementary Concept]
- 1-allyl-4-dodecanoyl-1-ethylpiperazin-1-ium [MeSH Supplementary Concept]
- 1-benzyl-3-(p-hydroxymethylphenyl)-5-methylfuro(3,2-c)pyrazole [MeSH Supplementary Concept]
- 1-formamido-10(1-2)-abeopupukeanane [MeSH Supplementary Concept]
- 1-hydroxy-3-methoxy-8-methyl-2-O-beta-D-glucopyranosylnaphthaline [MeSH Supplementary Concept]
- 10-acetylirciformonin B [MeSH Supplementary Concept]
- 12'-episatratoxin H [MeSH Supplementary Concept]
- 12-O-acetylazedarachin B [MeSH Supplementary Concept]
- 12-deoxyphorbol 13-palmitate [MeSH Supplementary Concept]
- 13-197 compound [MeSH Supplementary Concept]
- 13-O-acetylphorbol-20-oleate [MeSH Supplementary Concept]
- 15-acetylirciformonin B [MeSH Supplementary Concept]
- 16alpha,26-dihydroxylanosta-8,24-dien-3-one [MeSH Supplementary Concept]
- 17 alpha-Hydroxyprogesterone Caproate [MeSH Descriptor]
- 17,19-dimethylthioherbimycin A [MeSH Supplementary Concept]
- 17-(3'-(dimethylamino)-1'-propyl)amino-17-demethoxygeldanamycin [MeSH Supplementary Concept]
- 17-oxo-5-androsten-3beta-yl 4-chlorobenzoate [MeSH Supplementary Concept]
- 177Lu-DOTA-rituximab [MeSH Supplementary Concept]
- 188Re-MAG3-depreotide [MeSH Supplementary Concept]
- 1H-indole-2-carboxylic acid (2-(3-(4-(1H-indol-3-yl)-1-methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-indol-1-yl)-ethyl)-amide [MeSH Supplementary Concept]
- 1alpha,3-dipyrrolidino-androsta-3,5-diene-17-one [MeSH Supplementary Concept]
- 2,2'-diphenyl-3,3'-diindolylmethane [MeSH Supplementary Concept]
- 2,4-dichloro-N-(3-fluorophenyl)-5-(4-morpholinylsulfonyl)benzamide [MeSH Supplementary Concept]
- 2,5-dihydroxyphenylsulfonate [MeSH Supplementary Concept]
- 2-((1H-indol-2-yl-methylidene)amino)-5,6,7,8-tetrahydro-4H-cyclohepta(b)thiophene-3-carbonitrile [MeSH Supplementary Concept]
- 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester [MeSH Supplementary Concept]
- 2-(2-((4-cyclohexylbenzyl)amino)-6-((4-fluorophenyl)amino)-9H-purin-9-yl)ethyl sulfamate [MeSH Supplementary Concept]
- 2-(2-hydroxy-3-methylbutylthio)naphthalene-1,4-dione [MeSH Supplementary Concept]
- 2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide [MeSH Supplementary Concept]
- 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one [MeSH Supplementary Concept]
- 2-(3-chlorophenyloamino)-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole [MeSH Supplementary Concept]
- 2-(3-cyano-6-methoxyquinolin-2-ylthio)-N-(2-methoxy-5-methylphenyl)acetamide [MeSH Supplementary Concept]
- 2-(4-butoxyphenyl)-5-(4-hydroxyphenyl)pyrimidine [MeSH Supplementary Concept]
- 2-(4-chlorophenyl)-5-methyl-4-(2-(4-methyl-2-oxo-2H-chromen-7-yloxy)ethyl)-2H-1,2,4-triazol-3(4H)-one [MeSH Supplementary Concept]
- 2-(4-hydroxyanilino)-1,4-naphthoquinone [MeSH Supplementary Concept]
- 2-(4-methoxyanilino)-1,4-naphthoquinone [MeSH Supplementary Concept]
- 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid [MeSH Supplementary Concept]
- 2-(N-(2-hydroxyethyl)amino)methyl-3H-quinazolin-4-one [MeSH Supplementary Concept]
- 2-(benzylsulfinyl)ethyl pyridin-3-ylmethylcarbamodithioate [MeSH Supplementary Concept]
- 2-(p-chlorophenylsulfonylaminomethyl)-5-styryl-1,3,4-oxadiazole [MeSH Supplementary Concept]
- 2-aminoacetamido-10-(3, 5-dimethoxy)benzyl-9(10H)-acridone [MeSH Supplementary Concept]
- 2-chloro-N-(2-(2-(5-methylpyridin-2-ylamino)-2-oxoethylthio)benzo(d)thiazol-6-yl) acetamide [MeSH Supplementary Concept]
- 2-debenzoyl-2-(3-azidobenzyl)-10-propionyldocetaxel [MeSH Supplementary Concept]
- 2-ethyl-3-O-sulfamoylestra-1,3,5(10)16-tetraene [MeSH Supplementary Concept]
- 2-formamidopupukeanane [MeSH Supplementary Concept]
- 2-methoxy-5-(3-(5-methoxy-2,2-dimethyl-2H-chromen-8-yl)-3-oxoprop-1-en-1-yl)phenyl propionate [MeSH Supplementary Concept]
- 2-methoxy-6-icosynoic acid [MeSH Supplementary Concept]
- 2-phenylquinoline-4-carboxylic acid (1,1-dioxo-1H-1lambda6-benzo(b)thiophen-6-yl)amide [MeSH Supplementary Concept]
- 2-pyrone [MeSH Supplementary Concept]
- 20(R)-25-methoxyldammarane-3beta,12beta,20-triol [MeSH Supplementary Concept]
- 26-selenodioscin [MeSH Supplementary Concept]
- 26-thiodioscin [MeSH Supplementary Concept]
- 3,23-O-diacetyl-17-1,4'-bipiperidinyl betulinic amide [MeSH Supplementary Concept]
- 3,23-O-dihydroxy-17-1,4'-bipiperidinyl betulinic amide [MeSH Supplementary Concept]
- 3,5-bis(3,4,5-trimethoxybenzylidene)-1-methylpiperidine-4-one [MeSH Supplementary Concept]
- 3,7-dioxolanosta-8,24-dien-26-oic acid [MeSH Supplementary Concept]
- 3-(((2-fluorophenyl)amino)methyl)-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione [MeSH Supplementary Concept]
- 3-(((4-chlorophenyl)amino)methyl)-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione [MeSH Supplementary Concept]
- 3-((3-((4-(4-morpholinylmethyl)-1H-pyrrol-2-yl)methylene)-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl)-1,3-thiazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-((4-benzylpiperazino)methyl)-1H-indole [MeSH Supplementary Concept]
- 3-((6-((5-benzylidene-3,6-dioxopiperazin-2-ylidene)methyl)pyridin-3-yloxy)methyl)benzoic acid [MeSH Supplementary Concept]
- 3-(2-(4-fluorobenzyl)imidazo(2,1-beta)(1),(3)thiazol-6-yl)-2H-chromen-2-one [MeSH Supplementary Concept]
- 3-(2-aminoethyl)-5-(3-(4-butoxylphenyl)propylidene)thiazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-(4-(2-(diethylamino) ethoxy)phenyl)-7-methoxy-4-methylcoumarin [MeSH Supplementary Concept]
- 3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-7-methoxy-4-phenylcoumarin [MeSH Supplementary Concept]
- 3-(4-(benzo(d)(1,3)dioxol-5-yl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one [MeSH Supplementary Concept]
- 3-(5-cyano-4-(4-methyl-2-(methylamino)thiazol-5-yl)pyrimidin-2-ylamino)benzenesulfonamide [MeSH Supplementary Concept]
- 3-(5-methylisoxazol-3-yl)-2-styrylquinazolin-4(3H)-one [MeSH Supplementary Concept]
- 3-(dimethylamino-ethylamino)-8-oxo-8H-acenaphthol(1,2-b)pyrrole-9-carboxylic acid [MeSH Supplementary Concept]
- 3-O-(2'-acetoxy)benzoyl-2-glucopyranose [MeSH Supplementary Concept]
- 3-epipancratistatin [MeSH Supplementary Concept]
- 3-hydroxybakuchiol [MeSH Supplementary Concept]
- 3-iodoacetylamino-6-methoxybenzofuran-2-yl(3,5-trimethoxyphenyl)methanone [MeSH Supplementary Concept]
- 3-isopentenyloxyemodin [MeSH Supplementary Concept]
- 3-isopropyl-2-methyl-4-methyleneisoxazolidin-5-one [MeSH Supplementary Concept]
- 3-methylcyclopentylidene-(4-(4'-chlorophenyl)thiazol-2-yl)hydrazone [MeSH Supplementary Concept]
- 3a,7a,12-trihydroxy-16-norcassan-8,11,13-trien-13-al [MeSH Supplementary Concept]
- 3beta,24(S)-dihydroxycholesta-5,25-dien-7-one [MeSH Supplementary Concept]
- 3beta,25-dihydroxycholesta-5,23-dien-7-one [MeSH Supplementary Concept]
- 4'-O-demethyl-4-((4-hydroxymethyl)-1,2,3-triazol-1-yl)-4-deoxypodophyllotoxin cyclopentyl carbamate [MeSH Supplementary Concept]
- 4'-ester etoposide [MeSH Supplementary Concept]
- 4,4'-(3H,3'H-5,5'-bibenzimidazole-2,2'-diyl)dianiline [MeSH Supplementary Concept]
- 4-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide [MeSH Supplementary Concept]
- 4-(3',3'-dimethylallyloxy)-5-methyl-6-methoxyphthalide [MeSH Supplementary Concept]
- 4-(3-hydroxy-4-methoxyphenyl)-3-(4-hydroxyphenyl)-1-(3,4,5-trimethoxyphenyl)azetidin-2-one [MeSH Supplementary Concept]
- 4-amino-2-trifluoromethyl-phenyl retinate [MeSH Supplementary Concept]
- 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine [MeSH Supplementary Concept]
- 4-amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole [MeSH Supplementary Concept]
- 4-benzyl-3-((1-methylpyrrol-2-yl)methyl)-4,5-dihydro-1H-1,2,4-triazol-5-one [MeSH Supplementary Concept]
- 4-bromo-N-(5-ethyl-5H-pyrido(4,3-b)indol-8-yl)benzenesulfonamide [MeSH Supplementary Concept]
- 4-dodecylaminophenol [MeSH Supplementary Concept]
- 4-hydroxy-5-methylene-3-undecyclidenedihydrofuran-2(3H)-one [MeSH Supplementary Concept]
- 4-methylthiobutyl isothiocyanate [MeSH Supplementary Concept]
- 4-tert-butyl-2-((cyclohexylamino)methyl)-6-methylphenol [MeSH Supplementary Concept]
- 5'-chloro-2,3-didehydroindolo(2',3'-2,3)betulinic acid [MeSH Supplementary Concept]
- 5-((4-(5-(7,7-dimethyl-1,6-dioxaspiro(2.5)octan-5-yl)-3-methylpenta-2,4-dien-1-yl)cyclohexyl)amino)-5-oxopent-3-en-2-yl methylcarbamate [MeSH Supplementary Concept]
- 5-(2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxymethyl)-3-methyl-1,2,4-oxadiazole [MeSH Supplementary Concept]
- 5-(2-hydroxybenzylidene)-2-((4-phenoxyphenyl)imino)thiazolidin-4-one [MeSH Supplementary Concept]
- 5-(3-bromo-4-(dimethylamino)phenyl)-2,2-dimethyl-2,3,5,6-tetrahydrobenzo(a)phenanthridin-4(1H)-one [MeSH Supplementary Concept]
- 5-(ethoxycarbonyl)-6-methyl-4-(4-chlorophenyl)-3,4-dihydropyrimidin-2(1H)-one [MeSH Supplementary Concept]
- 5-amino-4-(1,3-benzothiazol-2-yl)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrol-3-one [MeSH Supplementary Concept]
- 5-amino-6-methoxy-2-(3',4',5'-trimethoxybenzoyl)quinoline [MeSH Supplementary Concept]
- 5-ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-3,4-dihydropyrimidin-2-(1H)-thione [MeSH Supplementary Concept]
- 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(5-methylfuran-2-yl)hepta-1,4,6-trien-3-one [MeSH Supplementary Concept]
- 5-hydroxy-6-(2-(1H-imidazol-4-yl)ethylamino)cholestan-3-ol [MeSH Supplementary Concept]
- 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone [MeSH Supplementary Concept]
- 5-methyl-2(pyridine-3-yl)-1-(3,4,5-trimethoxybenzyl)benzimidazole [MeSH Supplementary Concept]
- 6,7-bis(hydroxymethyl)-5-methyl-3-phenyl-1H,3H-pyrrolo(1,2-c)thiazole [MeSH Supplementary Concept]
- 6-((1-naphthylmethyl)sulfanyl)-9H-purine [MeSH Supplementary Concept]
- 6-(2-(2-(dimethylamino)ethylamino)ethylamino)-2-octyl-1H-benzo(de)isoquinoline-1,3(2H)-dione [MeSH Supplementary Concept]
- 6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone [MeSH Supplementary Concept]
- 6-(dodecylamino)-2-(3-(4-methylpiperazin-1-yl)propyl)-1H-benzo-(de)isoquinoline-1,3(2H)-dione [MeSH Supplementary Concept]
- 6-bromo-8-ethoxy-3-nitro-2H-chromene [MeSH Supplementary Concept]
- 6-methoxy-2-(4-(2-methyl-5-(3,4,5-trimethoxyphenyl)-1H-pyrrol-1-yl)phenyl)benzo(d)thiazole [MeSH Supplementary Concept]
- 6-methoxy-8-((2-furanylmethyl)amino)-4-methyl-5-(3-trifluoromethylphenyloxy)quinoline [MeSH Supplementary Concept]
- 6-pyrrolidinyl-2-(3-bromostyryl)quinazolin-4-one [MeSH Supplementary Concept]
- 7-(2-furanyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole [MeSH Supplementary Concept]
- 7-(benzyloxy)-6-(3-(dimethylamino)-propoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one [MeSH Supplementary Concept]
- 7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide [MeSH Supplementary Concept]
- 8,14-11,12-diepoxy-5,12-dihydroxy-3-oxo-10-abiet-13(15)-ene-16,18-diocic acid 16,12-lactone [MeSH Supplementary Concept]
- 8-(2-ethoxyphenyl)-7,8-dihydro-(1,3)dioxolo(4,5-g)quinolin-6(5H)-one [MeSH Supplementary Concept]
- 8-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-1-thia-4,8-diazaspiro(4.5)decan-3-one [MeSH Supplementary Concept]
- 8-(tosylamino)quinoline [MeSH Supplementary Concept]
- 8-cyclopentyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)-7-oxo-7,8-dihydropyrido(2,3-d)pyrimidine-6-carbonitrile [MeSH Supplementary Concept]
- 8-oxo-3-thiomorpholin-4-yl-8H-acenaphtho(1,2-b)pyrrole-9-carbonitrile [MeSH Supplementary Concept]
- 9-((6-chloropyridin-4-yl)methyl)-9H-carbazole-3-carbinol [MeSH Supplementary Concept]
- 9-azido-noscapine [MeSH Supplementary Concept]
- 9-methoxy-6-(piperazin-1-yl)-11H-indeno(1,2-c)quinoline-11-one O-3-(dimethylamino)propyl oxime [MeSH Supplementary Concept]
- 9-norbornyl-6-chloropurine [MeSH Supplementary Concept]
- AC1MMYR2 compound [MeSH Supplementary Concept]
- AD-01 peptide [MeSH Supplementary Concept]
- AG11 compound [MeSH Supplementary Concept]
- ALT-803 [MeSH Supplementary Concept]
- AMP423 [MeSH Supplementary Concept]
- ASG-5ME [MeSH Supplementary Concept]
- ATSP-7041 [MeSH Supplementary Concept]
- AZD4547 [MeSH Supplementary Concept]
- Akebia saponin PA [MeSH Supplementary Concept]
- Artenimol-R [MeSH Supplementary Concept]
- B19 monocarbonyl curcumin [MeSH Supplementary Concept]
- BBR3378 [MeSH Supplementary Concept]
- BC-DXI01 [MeSH Supplementary Concept]
- BE-26554A [MeSH Supplementary Concept]
- BE-54017 [MeSH Supplementary Concept]
- BGP-13 compound [MeSH Supplementary Concept]
- BKT140 [MeSH Supplementary Concept]
- BMS-748285 [MeSH Supplementary Concept]
- BMS-753493 [MeSH Supplementary Concept]
- BXI-61 [MeSH Supplementary Concept]
- CA-104 [MeSH Supplementary Concept]
- CH12 monoclonal antibody [MeSH Supplementary Concept]
- CIBP-4 peptide [MeSH Supplementary Concept]
- CR2408 [MeSH Supplementary Concept]
- CopA3 peptide, copris tripartitus [MeSH Supplementary Concept]
- D-Ser allo-aca peptide [MeSH Supplementary Concept]
- D6-MA compound [MeSH Supplementary Concept]
- DYZ-2-90 [MeSH Supplementary Concept]
- EDL-291 [MeSH Supplementary Concept]
- EGFR-lytic peptide [MeSH Supplementary Concept]
- EL102 compound [MeSH Supplementary Concept]
- EMD 521873 [MeSH Supplementary Concept]
- EPZ-5676 [MeSH Supplementary Concept]
- Ery5 compound [MeSH Supplementary Concept]
- FRAX597 [MeSH Supplementary Concept]
- FV-429 compound [MeSH Supplementary Concept]
- GK13 quinoxaline compound [MeSH Supplementary Concept]
- GN25 compound [MeSH Supplementary Concept]
- HaA4 peptide [MeSH Supplementary Concept]
- IMO-2055 [MeSH Supplementary Concept]
- IR-808DB [MeSH Supplementary Concept]
- IWR-1 compound [MeSH Supplementary Concept]
- JCA112 [MeSH Supplementary Concept]
- JCTH-4 [MeSH Supplementary Concept]
- JMV4463 [MeSH Supplementary Concept]
- JY-1-106 [MeSH Supplementary Concept]
- K873 compound [MeSH Supplementary Concept]
- KOS-1584 [MeSH Supplementary Concept]
- KSI-3716 [MeSH Supplementary Concept]
- LCH-7749944 [MeSH Supplementary Concept]
- LCL161 [MeSH Supplementary Concept]
- LDP-endostatin N-terminal fusion protein [MeSH Supplementary Concept]
- LL-37 peptide (17-32), human [MeSH Supplementary Concept]
- LY2603618 [MeSH Supplementary Concept]
- Leflunomide [MeSH Descriptor]
- Ly101-4B [MeSH Supplementary Concept]
- MBJ-0038 [MeSH Supplementary Concept]
- MBJ-0039 [MeSH Supplementary Concept]
- MBJ-0040 [MeSH Supplementary Concept]
- MDC-1112 [MeSH Supplementary Concept]
- MEHD7945A [MeSH Supplementary Concept]
- MTC-220 [MeSH Supplementary Concept]
- Mere15 peptide, meretrix meretrix [MeSH Supplementary Concept]
- N'-(7-fluoro-5-N-methyl-10H-indolo(3,2-b)quinolin-5-ium)-N,N-dimethylpropane-1,3-diamine [MeSH Supplementary Concept]
- N,N'-(2,2'-(hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1H-indene-2,1-diyl))bis(1-(2-cyclohexyl-2-(2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) [MeSH Supplementary Concept]
- N-((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl)-L-hydroxyproline dichloroplatinum(II) [MeSH Supplementary Concept]
- N-((6-bromo-2-methoxyquinolin-3-yl)(phenyl)methl)-N-(3,4-dichlorophenyl)-3-(4-methylpiperazin-1-yl)propanamide [MeSH Supplementary Concept]
- N-(12-ethyl-1-fluoro-3,6,9-trioxa-12-azatetradecan-14-yl)-6-iodoquinoxaline-2-carboxamide [MeSH Supplementary Concept]
- N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide [MeSH Supplementary Concept]
- N-(2-(piperidin-1-yl)phenyl)-2-(thiophen-2-yl)-1H-benzo(d)imidazole-4-carboxamide [MeSH Supplementary Concept]
- N-(2-arylethyl)isoquinoline [MeSH Supplementary Concept]
- N-(3,5-diiodophenyl)-2,2-dichloroacetamide [MeSH Supplementary Concept]
- N-(3-(2-((3-(thiophene-2-carboximidamido)benzyl)amino)ethyl)phenyl)thiophene-2-carboximidamide [MeSH Supplementary Concept]
- N-(3-(2-amino-6-methylpyrimidin-4-ylamino)phenyl)-4-(quinolin-4-ylamino)benzamide [MeSH Supplementary Concept]
- N-(3-(4-benzamido-1H-pyrrolo(3,2-c)pyridin-1-yl)phenyl)-4-morpholino-3-(trifluoromethyl)benzamide [MeSH Supplementary Concept]
- N-(3-amino-4-methoxyphenyl)-2-(2',4',6'-trimethoxyphenyl)ethenesulfonamide [MeSH Supplementary Concept]
- N-(3-phenylallylidene)-6-fluoro-1,8-(2,1-propoxy)-7-(4-methylpiperazin-1-yl)-quinolin-4(1H)-one-3-carbonyl hyarazine [MeSH Supplementary Concept]
- N-(4-((2-((cyclopropylcarbonyl)amino)imidazo(1,2-a)pyridin-6-yl)oxy)-3-fluorophenyl)-6-methyl-2-oxo-1-phenyl-1,2-dihydropyridine-3-carboxamide [MeSH Supplementary Concept]
- N-(4-(2-((3-(thiophene-2-carboximidamido)benzyl)amino)ethyl)phenyl)thiophene-2-carboximidamide [MeSH Supplementary Concept]
- N-(4-methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-aminium [MeSH Supplementary Concept]
- N-(4-trifluoromethylphenyl)retinamide [MeSH Supplementary Concept]
- N-(6,8-dimercaptooctanoyl)-2-aminoethanesulfonic zinc complex [MeSH Supplementary Concept]
- N-3-(1H-indol-5-yl)-5-pyridin-4-yl-pyrazine-2,3-diamine [MeSH Supplementary Concept]
- N-acetyl-5-ferrocenyl-3-(2-thienyl)-2-pyrazoline [MeSH Supplementary Concept]
- N-benzoyl-12-nitrodehydroabietylamine-7-one [MeSH Supplementary Concept]
- N-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide [MeSH Supplementary Concept]
- N-phenylacetyl-1,3,4,9-tetrahydro-beta-carboline [MeSH Supplementary Concept]
- N1-(6-quinolyl)-2-oxo-2-(1-(3-thienylmethyl)-1H-3-indolyl)acetamide [MeSH Supplementary Concept]
- N1-4-((biphenylsulphonyl)amino)phenyl-2-amino-3-phenyl-propionamide [MeSH Supplementary Concept]
- N2-(4-aminocyclohexyl)-9-cyclopentyl-N6-(6-(2-hydroxyphenyl)pyridin-3-ylmethyl)-9H-purine-2,6-diamine [MeSH Supplementary Concept]
- N3,N3'-(-cyclohexane-1,4-diyl)bis(N8-benzhydryl-5-(2-(methylamino)propanamido)-6-oxooctahydropyrrolo(1,2-a)(1,5)diazocine-3,8(4H)-dicarboxamide) [MeSH Supplementary Concept]
- NC-6301 [MeSH Supplementary Concept]
- NL-608 [MeSH Supplementary Concept]
- NRC-AN-019 [MeSH Supplementary Concept]
- NSC80467 [MeSH Supplementary Concept]
- NUC-1031 [MeSH Supplementary Concept]
- OXi8007 compound [MeSH Supplementary Concept]
- PF-4942847 [MeSH Supplementary Concept]
- PS-101 [MeSH Supplementary Concept]
- Pamidronate [MeSH Descriptor]
- Panitumumab [MeSH Descriptor]
- PsT-1 peptide, phyllomedusa sauvagei [MeSH Supplementary Concept]
- Pt(O,O'-acac)(gamma-acac)(DMS) [MeSH Supplementary Concept]
- Pt2(3-butylpyridine)4(berenil)2 [MeSH Supplementary Concept]
- Pt2(3-ethylpyridine)4(berenil)2 [MeSH Supplementary Concept]
- R1498 compound [MeSH Supplementary Concept]
- RCE-4 compound [MeSH Supplementary Concept]
- RG7112 [MeSH Supplementary Concept]
- RL1B monoclonal antibody [MeSH Supplementary Concept]
- RSL3 compound [MeSH Supplementary Concept]
- Rawq01 compound [MeSH Supplementary Concept]
- Ro5203280 [MeSH Supplementary Concept]
- SBI-0087702 [MeSH Supplementary Concept]
- SBI-0089410 [MeSH Supplementary Concept]
- SC-2001 [MeSH Supplementary Concept]
- SC-59 compound [MeSH Supplementary Concept]
- SM1044 [MeSH Supplementary Concept]
- SW044248 [MeSH Supplementary Concept]
- T-10 stemonamide [MeSH Supplementary Concept]
- T-18 stemonamide [MeSH Supplementary Concept]
- T83 compound [MeSH Supplementary Concept]
- TAK-632 [MeSH Supplementary Concept]
- TE-64562 [MeSH Supplementary Concept]
- TIC10 compound [MeSH Supplementary Concept]
- TMP70W polysaccharide [MeSH Supplementary Concept]
- Troglitazone [MeSH Descriptor]
- U-104 [MeSH Supplementary Concept]
- VBY-825 [MeSH Supplementary Concept]
- VI-14 flavonoid [MeSH Supplementary Concept]
- VLX40 [MeSH Supplementary Concept]
- Verteporfin [MeSH Descriptor]
- WYC02-9 [MeSH Supplementary Concept]
- XL019 compound [MeSH Supplementary Concept]
- YHHU0895 [MeSH Supplementary Concept]
- YM753 compound [MeSH Supplementary Concept]
- ZL-004 [MeSH Supplementary Concept]
- acidic serine protease, neanthes japonica [MeSH Supplementary Concept]
- ajugalide-B [MeSH Supplementary Concept]
- altissinol A [MeSH Supplementary Concept]
- altissinol B [MeSH Supplementary Concept]
- anthrapyridone CO1 [MeSH Supplementary Concept]
- ascotrichic acid B [MeSH Supplementary Concept]
- asperterrestide A [MeSH Supplementary Concept]
- benzo(1,3)dioxolo-5-carboxylic acid (4-(2-diethylaminoethylcarbamoyl)-2-iodo-5-methoxyphenyl)amide [MeSH Supplementary Concept]
- benzoperimidine BP1 [MeSH Supplementary Concept]
- biaketide [MeSH Supplementary Concept]
- bis(N-furfuryl-N-(2-phenylethyl)dithiocarbamato-S,S')zinc(II) [MeSH Supplementary Concept]
- bis(mu-methyl-N-(dithiocarboxy-kS,kS')-N-methylglycinato)(bis(methyl-N-(dithiocarboxy-kS,kS')-N-methylglycinato)zinc(II)) [MeSH Supplementary Concept]
- bis-dehydroxy-curcumin [MeSH Supplementary Concept]
- bouillonamide A [MeSH Supplementary Concept]
- caffeic acid undecyl ester [MeSH Supplementary Concept]
- calcipotriene [MeSH Supplementary Concept]
- calyxin Y [MeSH Supplementary Concept]
- casiopeina II-glycine [MeSH Supplementary Concept]
- chloro(5-dimethyl-2-phenyl-4-((pyridin-2-ylmethylene)amino)-1,2-dihydro-pyrazol-3-one)(triphenylphosphine)copper(I) [MeSH Supplementary Concept]
- cifetrelin [MeSH Supplementary Concept]
- cis-dichlorobis(3,4,7,8-tetramethyl-1,10-phenanthroline)rhodium(III) chloride [MeSH Supplementary Concept]
- cladoniamide G [MeSH Supplementary Concept]
- cycloforskamide [MeSH Supplementary Concept]
- daphneresiniferin B [MeSH Supplementary Concept]
- debromoantazirine [MeSH Supplementary Concept]
- decumbenone C [MeSH Supplementary Concept]
- dehydropachymic acid [MeSH Supplementary Concept]
- desmethyl-lasiodiplodin [MeSH Supplementary Concept]
- digitoxigenin 3-O-(O-glucopyranosyl-(1-4)-2-O-acetyldigitalopyranoside) [MeSH Supplementary Concept]
- dimethyl-5-acetyl-4-methyl-6-(4-methylphenylimino)-6H-thiopyran-2,3-dicarboxylate [MeSH Supplementary Concept]
- dimethylarsino-cysteine [MeSH Supplementary Concept]
- diplasterioside A [MeSH Supplementary Concept]
- diplasterioside B [MeSH Supplementary Concept]
- dithiiranylmethyloxy azaxanthone [MeSH Supplementary Concept]
- divarine [MeSH Supplementary Concept]
- dracorhodin [MeSH Supplementary Concept]
- endostatin-LDP C-terminal fusion protein [MeSH Supplementary Concept]
- erythrazole A [MeSH Supplementary Concept]
- erythrazole B [MeSH Supplementary Concept]
- eta5-cyclopentadienyl(2,2'-bipyridyl)(triphenylphosphane)ruthenium(II) [MeSH Supplementary Concept]
- etirinotecan pegol [MeSH Supplementary Concept]
- excavatine A [MeSH Supplementary Concept]
- fermenticin HV6b, Lactobacillus fermentum [MeSH Supplementary Concept]
- feruloylarabinose [MeSH Supplementary Concept]
- flurbiprofen benzyl nitrate [MeSH Supplementary Concept]
- fradcarbazole A [MeSH Supplementary Concept]
- fradcarbazole B [MeSH Supplementary Concept]
- fradcarbazole C [MeSH Supplementary Concept]
- frutalin [MeSH Supplementary Concept]
- furospongolide [MeSH Supplementary Concept]
- fusarisetin A [MeSH Supplementary Concept]
- ganodone [MeSH Supplementary Concept]
- gardovatine [MeSH Supplementary Concept]
- glaucocalyxin A [MeSH Supplementary Concept]
- glaucocalyxin B [MeSH Supplementary Concept]
- hailongin [MeSH Supplementary Concept]
- haliclonadiamine [MeSH Supplementary Concept]
- hemicalide [MeSH Supplementary Concept]
- hexahydrocurcumin [MeSH Supplementary Concept]
- hirsutanol A [MeSH Supplementary Concept]
- hypocrolide A [MeSH Supplementary Concept]
- hyrtimomine A [MeSH Supplementary Concept]
- ianthelline [MeSH Supplementary Concept]
- indole-3-ethyl isothiocyanate [MeSH Supplementary Concept]
- infigratinib [MeSH Supplementary Concept]
- ircinolin A [MeSH Supplementary Concept]
- irinotecan sucrosofate [MeSH Supplementary Concept]
- isolinderanolide B [MeSH Supplementary Concept]
- japonicone A [MeSH Supplementary Concept]
- jaridonin [MeSH Supplementary Concept]
- klymollin M [MeSH Supplementary Concept]
- lactoferricin 4-14, human [MeSH Supplementary Concept]
- larifan [MeSH Supplementary Concept]
- linearolide A [MeSH Supplementary Concept]
- lodamin [MeSH Supplementary Concept]
- mallotus B [MeSH Supplementary Concept]
- manganese(II) 5,10,15,20-tetrakis(4-N-methylpyridine)porphyrin [MeSH Supplementary Concept]
- marchantin M [MeSH Supplementary Concept]
- meayamycin B [MeSH Supplementary Concept]
- merestinib [MeSH Supplementary Concept]
- methyl 1-hydroxy-6-phenyl-4-(trifluoromethyl)-1H-indole-2-carboxylate [MeSH Supplementary Concept]
- methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate [MeSH Supplementary Concept]
- methyl N,N'-di(quinolin-3-ylcarbonyl)imidoselenocarbamate [MeSH Supplementary Concept]
- mollenyne A [MeSH Supplementary Concept]
- monacolin O [MeSH Supplementary Concept]
- monacolin P [MeSH Supplementary Concept]
- monascuspiloin [MeSH Supplementary Concept]
- mycalol [MeSH Supplementary Concept]
- myrrhanol C [MeSH Supplementary Concept]
- neoN-methylsansalvamide [MeSH Supplementary Concept]
- neoalbaconol [MeSH Supplementary Concept]
- nishindanol [MeSH Supplementary Concept]
- oldhamianoside II [MeSH Supplementary Concept]
- parasiticin C [MeSH Supplementary Concept]
- periconiasin A [MeSH Supplementary Concept]
- periconiasin B [MeSH Supplementary Concept]
- periconiasin C [MeSH Supplementary Concept]
- periplogenin 3-O-(O-glucopyranosyl-(1-4)-O-glucopyranosyl-(1-4)-cymaropyranoside) [MeSH Supplementary Concept]
- petronigrione [MeSH Supplementary Concept]
- phenanthriplatin [MeSH Supplementary Concept]
- phomazine A [MeSH Supplementary Concept]
- phomazine B [MeSH Supplementary Concept]
- phomazine C [MeSH Supplementary Concept]
- pidilizumab [MeSH Supplementary Concept]
- pierreione B [MeSH Supplementary Concept]
- preussochromone A [MeSH Supplementary Concept]
- prolyl-leucyl-leucyl-glutaminyl-lysine [MeSH Supplementary Concept]
- propyl-2-(8-(3,4-difluorobenzyl)-2',5'-dioxo-8-azaspiro(bicyclo(3.2.1)octane-3,4'-imidazolidine)-1'-yl)acetate [MeSH Supplementary Concept]
- protoapigenone [MeSH Supplementary Concept]
- przewalskone [MeSH Supplementary Concept]
- psiguadial C [MeSH Supplementary Concept]
- psiguadial D [MeSH Supplementary Concept]
- pterosin B [MeSH Supplementary Concept]
- pyrazolopyrimidoacridine PPAC2 [MeSH Supplementary Concept]
- pyrenochaetic acid D [MeSH Supplementary Concept]
- pyrenocine J [MeSH Supplementary Concept]
- raddeanin A [MeSH Supplementary Concept]
- rhamnolipid-1, pseudomonas aeruginosa [MeSH Supplementary Concept]
- ridaifen-SB8 [MeSH Supplementary Concept]
- sann-joong-kuey-jian-tang [MeSH Supplementary Concept]
- sanpi pingwei [MeSH Supplementary Concept]
- secoemestrin D [MeSH Supplementary Concept]
- simplextone C [MeSH Supplementary Concept]
- smardaesidin A [MeSH Supplementary Concept]
- spiruchostatin D [MeSH Supplementary Concept]
- sprengerinin C [MeSH Supplementary Concept]
- stellarmedin A protein, Stellaria media [MeSH Supplementary Concept]
- sumalarin A [MeSH Supplementary Concept]
- sumalarin B [MeSH Supplementary Concept]
- sumalarin C [MeSH Supplementary Concept]
- telekin [MeSH Supplementary Concept]
- temsirolimus [MeSH Supplementary Concept]
- tenovin-6 [MeSH Supplementary Concept]
- terreumol A [MeSH Supplementary Concept]
- terreumol C [MeSH Supplementary Concept]
- terreumol D [MeSH Supplementary Concept]
- tetraethyl anthracene-9,10-diyl-9,10-bis(phosphonate) [MeSH Supplementary Concept]
- tetrakis(diisopropylguanidino) zinc phthalocyanine [MeSH Supplementary Concept]
- thelephantin O [MeSH Supplementary Concept]
- triflorcas [MeSH Supplementary Concept]
- triticuside A [MeSH Supplementary Concept]
- tritoniopsin B [MeSH Supplementary Concept]
- ulocuplumab [MeSH Supplementary Concept]
- vitexin 6 [MeSH Supplementary Concept]
- wikyungtang [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Antineoplastic without further specification [ICD-11 Extension code]
- Other antineoplastic drugs [Bloc CIM-11]
MedlinePlus topic(s)
- cancer chemotherapy [MedlinePlus Topic]
Metaterm(s)
- oncology [CISMeF Metaterm]
Ne pas confondre avec
- anticarcinogenic agents [MeSH Descriptor]
- drug therapy [MeSH Descriptor]
Record concept(s)
- antineoplastic agents [MeSH concept]
See also
- anticarcinogenic agents [MeSH Descriptor]
- chemoembolization, therapeutic [MeSH Descriptor]
- chemotherapy, cancer, regional perfusion [MeSH Descriptor]
- cytotoxins [MeSH Descriptor]
- infusions, Intra-Arterial [MeSH Descriptor]
- interferon inducers [MeSH Descriptor]
- neoplasms [MeSH Descriptor]
- tumor lysis syndrome [MeSH Descriptor]
See also (suggested by CISMeF)
- amsacrine [MeSH Descriptor]
- antineoplastic protocols [MeSH Descriptor]
- chemoradiotherapy [MeSH Descriptor]
- drug resistance, neoplasm [MeSH Descriptor]
- mitosis [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,2,3-O-acetyl-1,2,3-demethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine [MeSH Supplementary Concept]
- 1,2-diaminocyclohexaneplatinum II citrate [MeSH Supplementary Concept]
- 1,2-dithiol-3-thione [MeSH Supplementary Concept]
- 1,3,4,5,6,7,8,10-octahydro-14-hydroxy-12-methoxy-11-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-9,2,5-benzoxanthiaazacyclododecine-10-one [MeSH Supplementary Concept]
- 1,3,4,5,6,7,8,9,10,12-decahydro-16-hydroxy-14-methoxy-13-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-11,2,5-benzoxathiaazacyclotetradecine-12-one [MeSH Supplementary Concept]
- 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one [MeSH Supplementary Concept]
- 1,9-dimethylmethylene blue [MeSH Supplementary Concept]
- 1-(2-(2-((7-chloroquinolin-4-yl)amino)ethyl-methylamino)ethylamino)-4-methylthioxanthen-9-one [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea [MeSH Supplementary Concept]
- 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol [MeSH Supplementary Concept]
- 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro(2,3-h)quinolin-2(1H)-one [MeSH Supplementary Concept]
- 1-(4-carboxyphenyl)-3,3-dimethyltriazene [MeSH Supplementary Concept]
- 1-arabinofuranosylcytosine-5'-stearylphosphate [MeSH Supplementary Concept]
- 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid [MeSH Supplementary Concept]
- 1-cyclopropyl-6-hydroxy-8-methyl-4-oxo-7-(1,2,3,4-tetrahydro-2-isoquinolyl)-1,4-dihydroquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 10,11-methylenedioxy-20-camptothecin [MeSH Supplementary Concept]
- 10-deazaaminopterin [MeSH Supplementary Concept]
- 1843U89 [MeSH Supplementary Concept]
- 2'-deoxy-2'-methylenecytidine [MeSH Supplementary Concept]
- 2'fluoro-2'-deoxyuridine [MeSH Supplementary Concept]
- 2,3-dihydro-1H-imidazo(1,2-b)pyrazole [MeSH Supplementary Concept]
- 2,3-dihydro-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1H,12H-benzo(de)pyrano(3',4'-6,7)indolizino(1,2-b)quinoline-10,13(9H,15H)-dione [MeSH Supplementary Concept]
- 2,3-dihydroindolizino(7,6,5-kl)acridinium chloride [MeSH Supplementary Concept]
- 2,3-dimethoxy-8,9-methylenedioxy-11H-indeno(1,2-c)isoquinoline [MeSH Supplementary Concept]
- 2,4-diamino-5-adamantyl-6-methylpyrimidine [MeSH Supplementary Concept]
- 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone [MeSH Supplementary Concept]
- 2,5-bis(4-hydroxy-3-methoxybenzylidene)cyclopentanone [MeSH Supplementary Concept]
- 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide [MeSH Supplementary Concept]
- 2-(2'-(dimethylamino)ethyl)-1,2-dihydro-7-ethoxydibenz(de,h)isoquinoline-1,3-dione [MeSH Supplementary Concept]
- 2-(2-dimethylamino)-6-thia-2-azabenzo(def)chrysene-1,3-dione [MeSH Supplementary Concept]
- 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide [MeSH Supplementary Concept]
- 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-(2'',6''-di-O-(3'''-(4-fluorophenylpropanoyl)))galactosyl-4H-chromen-4-one [MeSH Supplementary Concept]
- 2-(4-methoxyphenyl)-5-((4-methylpiperazin-1-yl)-3H-imidazo(4,5-b)pyridin-2-yl)-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 2-acyl-5,8-dimethoxy-1,4-naphthoquinone [MeSH Supplementary Concept]
- 2-amino-1,3,4-thiadiazole [MeSH Supplementary Concept]
- 2-nitro-7-methoxynaphtho(2-1b)furan [MeSH Supplementary Concept]
- 3',5'-dichloromethotrexate [MeSH Supplementary Concept]
- 3'-O-benzyl-2'-deoxy-5-trifluoromethyluridine [MeSH Supplementary Concept]
- 3'-amino-2',3'-dideoxyuridine [MeSH Supplementary Concept]
- 3'-deamino-3'-hydroxydoxorubicin [MeSH Supplementary Concept]
- 3,4-dihydroxybenzohydroxamic acid [MeSH Supplementary Concept]
- 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid [MeSH Supplementary Concept]
- 3,9-dibromo-12-(4-O-methylglucopyranosyl)-6,7.12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione [MeSH Supplementary Concept]
- 3-(1-deoxyribofuranosyl)benzamide [MeSH Supplementary Concept]
- 3-Iodobenzylguanidine [MeSH Descriptor]
- 3-O-(N-(phenylsulfonyl)carbamoyl-17beta-N-(phenylsulfonyl)amide)betulinic acid [MeSH Supplementary Concept]
- 3-O-(glucopyranosyl-1-4-arabinopyranosyl)hederagenin [MeSH Supplementary Concept]
- 3-O-alpha-L-arabinopyranosyl-oleanolic acid [MeSH Supplementary Concept]
- 3-O-coumaroylbetulinic acid [MeSH Supplementary Concept]
- 3-amino-7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione [MeSH Supplementary Concept]
- 3-hydroxypyridin-4-one [MeSH Supplementary Concept]
- 4'-O-demethyl-4-(4''-(benzimidazol-2''-yl)anilino)-4-desoxypodophyllotoxin [MeSH Supplementary Concept]
- 4,11-dimethoxynaphtho(2,3-f)indole-5,10-dione [MeSH Supplementary Concept]
- 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione [MeSH Supplementary Concept]
- 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline [MeSH Supplementary Concept]
- 4-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide [MeSH Supplementary Concept]
- 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid [MeSH Supplementary Concept]
- 4-(N-methyl-N-(4-(trifluoromethyl)phenyl)sulfamoyl) benzoic acid [MeSH Supplementary Concept]
- 4-S-cysteaminylphenol [MeSH Supplementary Concept]
- 4-amidinoindan-1-one 2'-amidinohydrazone [MeSH Supplementary Concept]
- 4-aminobenzamidine [MeSH Supplementary Concept]
- 4-benzoyl-1-(4-methyl-imidazol-5-yl)carbonylthiosemicarbazide [MeSH Supplementary Concept]
- 4-demethoxy-3'-deamino-3'-hydroxydoxorubicin [MeSH Supplementary Concept]
- 4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin [MeSH Supplementary Concept]
- 4-ipomeanol [MeSH Supplementary Concept]
- 4-methoxybenzo(a)phenazine-11-carboxylic acid (2-(dimethylamino)-1-methylethyl)amide [MeSH Supplementary Concept]
- 4-methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one [MeSH Supplementary Concept]
- 4-phenylbutyric acid [MeSH Supplementary Concept]
- 5'-deoxy-5'-S-isobutylthioadenosine [MeSH Supplementary Concept]
- 5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7H)-4,6-dione [MeSH Supplementary Concept]
- 5,11-dimethyl-5H-indolo(2,3-b)quinoline [MeSH Supplementary Concept]
- 5,8-bis(2-aminoethylamino)-1-azaanthracene-9,10-dione [MeSH Supplementary Concept]
- 5-(2-(5-chloroindol-3-yl)vinyl)pyrazole [MeSH Supplementary Concept]
- 5-(N,N-hexamethylene)amiloride [MeSH Supplementary Concept]
- 5-(aminomethyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-bromouridine [MeSH Supplementary Concept]
- 5-ethyl-9,10-difluoro-1,4,5,13-tetrahydro-5-hydroxy-3H,15H-oxepino(3',4'-6,7)indolizino(1,2-b)quinoline-3,15-dione [MeSH Supplementary Concept]
- 5-hydroxymethyl-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-phenyl-2-(2'-(benzimidazol-5''-yl)benzimidazol-5'-yl)benzimidazole [MeSH Supplementary Concept]
- 5109870 compound [MeSH Supplementary Concept]
- 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one [MeSH Supplementary Concept]
- 6-(3-(2-hydroxyethyl)amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno(1,2-)isoquinoline [MeSH Supplementary Concept]
- 6-O-palmitoylascorbic acid [MeSH Supplementary Concept]
- 6-acyl-5,8-dimethoxy-1,4-naphthoquinone [MeSH Supplementary Concept]
- 6-anilino-5,8-quinolinedione [MeSH Supplementary Concept]
- 6-chloropurine [MeSH Supplementary Concept]
- 6-chrysenamine [MeSH Supplementary Concept]
- 6-heptyne-2,5-diamine [MeSH Supplementary Concept]
- 7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione [MeSH Supplementary Concept]
- 7-(4-(4-tert-butylbenzyloxy)-1H-indazol-3-ylmethylsulfanyl)-4-methylcoumarin [MeSH Supplementary Concept]
- 7-hydroxystaurosporine [MeSH Supplementary Concept]
- 7-tert-butyldimethylsilyl-10-hydroxyhomocamptothecin [MeSH Supplementary Concept]
- 8-azabatracylin [MeSH Supplementary Concept]
- 8-chloro-cyclic adenosine monophosphate [MeSH Supplementary Concept]
- 8-desaminobatracylin [MeSH Supplementary Concept]
- 9'-fluoro-10'-(4-methyl-1-piperazinyl)-7'-oxospiro(cyclopropane-1,3'(2'H)-(7H)pyrido(1,2,3-de)(1,4)benzoxazine)-6'-carboxylic acid [MeSH Supplementary Concept]
- 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-aminocamptothecin [MeSH Supplementary Concept]
- 9-arabinofuranosylguanine [MeSH Supplementary Concept]
- 9-bromophenazine-4-carboxamide [MeSH Supplementary Concept]
- 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 [MeSH Supplementary Concept]
- 9-deoxy-delta-9-prostaglandin D2 [MeSH Supplementary Concept]
- 9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)- [MeSH Supplementary Concept]
- A 62176 [MeSH Supplementary Concept]
- A 85226 [MeSH Supplementary Concept]
- ACH 702 [MeSH Supplementary Concept]
- AQ4N [MeSH Supplementary Concept]
- AZD5991 [MeSH Supplementary Concept]
- Abiraterone Acetate [MeSH Descriptor]
- Adenosine-5'-(N-ethylcarboxamide) [MeSH Descriptor]
- Afatinib [MeSH Descriptor]
- Albumin-Bound Paclitaxel [MeSH Descriptor]
- Alitretinoin [MeSH Descriptor]
- Arsenic Trioxide [MeSH Descriptor]
- Artesunate [MeSH Descriptor]
- Atrasentan [MeSH Descriptor]
- Axitinib [MeSH Descriptor]
- B72.3 antibody [MeSH Supplementary Concept]
- BBR 3464 [MeSH Supplementary Concept]
- BCT-100 [MeSH Supplementary Concept]
- BE 10988 [MeSH Supplementary Concept]
- BE 13793C [MeSH Supplementary Concept]
- BE 22179 [MeSH Supplementary Concept]
- BM 2419-1 [MeSH Supplementary Concept]
- BM 2419-2 [MeSH Supplementary Concept]
- Bexarotene [MeSH Descriptor]
- Bortezomib [MeSH Descriptor]
- C 1311 [MeSH Supplementary Concept]
- CB 3717 [MeSH Supplementary Concept]
- CD 437 [MeSH Supplementary Concept]
- CJ 12371 [MeSH Supplementary Concept]
- CJ 12372 [MeSH Supplementary Concept]
- CJ 12373 [MeSH Supplementary Concept]
- CPUY013 compound [MeSH Supplementary Concept]
- Cl-DACA [MeSH Supplementary Concept]
- Crizotinib [MeSH Descriptor]
- DAB(486)-interleukin 2 [MeSH Supplementary Concept]
- DCZ3301 [MeSH Supplementary Concept]
- DFP-10825 [MeSH Supplementary Concept]
- DN604 [MeSH Supplementary Concept]
- DWA 2114 [MeSH Supplementary Concept]
- DX 52-1 [MeSH Supplementary Concept]
- Dasatinib [MeSH Descriptor]
- Debio 0617B [MeSH Supplementary Concept]
- EKB 569 [MeSH Supplementary Concept]
- Emitefur [MeSH Supplementary Concept]
- Erlotinib Hydrochloride [MeSH Descriptor]
- Everolimus [MeSH Descriptor]
- FD 501 [MeSH Supplementary Concept]
- FK 156 [MeSH Supplementary Concept]
- GL 331 [MeSH Supplementary Concept]
- GR 122222X [MeSH Supplementary Concept]
- GSK2636771 [MeSH Supplementary Concept]
- Gatifloxacin [MeSH Descriptor]
- Gefitinib [MeSH Descriptor]
- Gemifloxacin [MeSH Descriptor]
- ICI 198583 [MeSH Supplementary Concept]
- IDN 5109 [MeSH Supplementary Concept]
- IMB-6G [MeSH Supplementary Concept]
- INCB 54828-101 [MeSH Supplementary Concept]
- INCB054329 [MeSH Supplementary Concept]
- INCB057643 [MeSH Supplementary Concept]
- ISIS 5132 [MeSH Supplementary Concept]
- Imatinib Mesylate [MeSH Descriptor]
- Imiquimod [MeSH Descriptor]
- ImuVert [MeSH Supplementary Concept]
- Interferon alpha-2 [MeSH Descriptor]
- Interferon beta-1a [MeSH Descriptor]
- Interleukin-2 [MeSH Descriptor]
- Interleukin-4 [MeSH Descriptor]
- Irinotecan [MeSH Descriptor]
- KH 1060 [MeSH Supplementary Concept]
- KRN 5500 [MeSH Supplementary Concept]
- KRN 7000 [MeSH Supplementary Concept]
- LB100 [MeSH Supplementary Concept]
- LCTA-2034 [MeSH Supplementary Concept]
- LMP517 [MeSH Supplementary Concept]
- Lapatinib [MeSH Descriptor]
- Letrozole [MeSH Descriptor]
- MEDI0641 [MeSH Supplementary Concept]
- MP 412 [MeSH Supplementary Concept]
- Moxifloxacin [MeSH Descriptor]
- N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea [MeSH Supplementary Concept]
- N(1), N(12)-diethylspermine [MeSH Supplementary Concept]
- N(1),N(11)-diethylnorspermine [MeSH Supplementary Concept]
- N(1),N(14)-bis(ethyl)homospermine [MeSH Supplementary Concept]
- N,N'-dimethylnitrosourea [MeSH Supplementary Concept]
- N,N-bis(3-(5-bromoacridine-4-carboxamido)propyl)methylamine [MeSH Supplementary Concept]
- N,N-bis(3-(5-methylacridine-4-carboxamido)propyl)methylamine [MeSH Supplementary Concept]
- N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide [MeSH Supplementary Concept]
- N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide [MeSH Supplementary Concept]
- N-(2-(dimethylamino)ethyl)-5-methyl-4-acridinecarboxamide [MeSH Supplementary Concept]
- N-(3-((1,4'-bipiperidin)-1'-yl)propyl)-6-(4-(4-methylpiperazin-1-yl)phenyl)picolinamide [MeSH Supplementary Concept]
- N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide [MeSH Supplementary Concept]
- NB 506 [MeSH Supplementary Concept]
- NC-4016 [MeSH Supplementary Concept]
- NK 121 [MeSH Supplementary Concept]
- NSC 366140 [MeSH Supplementary Concept]
- NSC 659687 [MeSH Supplementary Concept]
- NSC311153 [MeSH Supplementary Concept]
- NU-ICRF 500 [MeSH Supplementary Concept]
- Non-Ovlon [MeSH Supplementary Concept]
- O(6)-benzylguanine [MeSH Supplementary Concept]
- ON 01910 [MeSH Supplementary Concept]
- OR-2100 [MeSH Supplementary Concept]
- Oxaliplatin [MeSH Descriptor]
- PD 134308 [MeSH Supplementary Concept]
- PD 135042 [MeSH Supplementary Concept]
- PD 138312 [MeSH Supplementary Concept]
- PD 160793 [MeSH Supplementary Concept]
- PD 161148 [MeSH Supplementary Concept]
- PF 03376056 [MeSH Supplementary Concept]
- PK 11195 [MeSH Supplementary Concept]
- PNU-286607 [MeSH Supplementary Concept]
- Panobinostat [MeSH Descriptor]
- Pemetrexed [MeSH Descriptor]
- PhAc-ALGP-doxorubicin [MeSH Supplementary Concept]
- RV 538 [MeSH Supplementary Concept]
- Roscovitine [MeSH Descriptor]
- S 38809 [MeSH Supplementary Concept]
- S 9788 [MeSH Supplementary Concept]
- S-allylcysteine [MeSH Supplementary Concept]
- S-lactoylglutathione [MeSH Supplementary Concept]
- SERPIN-B5 [MeSH Supplementary Concept]
- SOR-C13 [MeSH Supplementary Concept]
- SR 103 [MeSH Supplementary Concept]
- SR 107 [MeSH Supplementary Concept]
- Sorafenib [MeSH Descriptor]
- TAN 1496 A [MeSH Supplementary Concept]
- TAN 1496 C [MeSH Supplementary Concept]
- TAN 1496 E [MeSH Supplementary Concept]
- TAN 1518 A [MeSH Supplementary Concept]
- TAN 1518 B [MeSH Supplementary Concept]
- TAT 59 [MeSH Supplementary Concept]
- TIC10 compound [MeSH Supplementary Concept]
- TPME monoterpene derivative [MeSH Supplementary Concept]
- Talaporfin [MeSH Supplementary Concept]
- Tirapazamine [MeSH Descriptor]
- UCT 1072M1 [MeSH Supplementary Concept]
- UCT 1072M2 [MeSH Supplementary Concept]
- UFT(R) drug [MeSH Supplementary Concept]
- VRT 125853 [MeSH Supplementary Concept]
- VUFB 13468 [MeSH Supplementary Concept]
- Vemurafenib [MeSH Descriptor]
- Vorinostat [MeSH Descriptor]
- WCK 1734 [MeSH Supplementary Concept]
- WRC 213 [MeSH Supplementary Concept]
- WT161 [MeSH Supplementary Concept]
- XL647 [MeSH Supplementary Concept]
- ZD 9331 [MeSH Supplementary Concept]
- ZK 112993 [MeSH Supplementary Concept]
- ZKK-13 [MeSH Supplementary Concept]
- acalabrutinib [MeSH Supplementary Concept]
- acemannan [MeSH Supplementary Concept]
- adagrasib [MeSH Supplementary Concept]
- afimoxifene [MeSH Supplementary Concept]
- alatrofloxacin [MeSH Supplementary Concept]
- aldesleukin [MeSH Supplementary Concept]
- alliin [MeSH Supplementary Concept]
- alpha,beta-methyleneadenosine 5'-triphosphate [MeSH Supplementary Concept]
- alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide [MeSH Supplementary Concept]
- alpha-lapachone [MeSH Supplementary Concept]
- alpha-methylornithine [MeSH Supplementary Concept]
- aluminum tetrasulfophthalocyanine [MeSH Supplementary Concept]
- alvocidib [MeSH Supplementary Concept]
- am 580 [MeSH Supplementary Concept]
- ambamustine [MeSH Supplementary Concept]
- ametantrone [MeSH Supplementary Concept]
- amifloxacin [MeSH Supplementary Concept]
- ammonium trichloro(dioxoethylene-O,O'-)tellurate [MeSH Supplementary Concept]
- ammonium tungsten antimonate hydroxide oxide [MeSH Supplementary Concept]
- amonafide [MeSH Supplementary Concept]
- amrubicin [MeSH Supplementary Concept]
- amsacrine [MeSH Descriptor]
- anaxirone [MeSH Supplementary Concept]
- animacroxam [MeSH Supplementary Concept]
- anordrin [MeSH Supplementary Concept]
- antistasin [MeSH Supplementary Concept]
- antofloxacin [MeSH Supplementary Concept]
- apatinib [MeSH Supplementary Concept]
- apaziquone [MeSH Supplementary Concept]
- arabinosyl-6-mercaptopurine [MeSH Supplementary Concept]
- ardisin [MeSH Supplementary Concept]
- arginine butyrate [MeSH Supplementary Concept]
- arginyl-glycyl-aspartic acid [MeSH Supplementary Concept]
- ascorbate-2-phosphate [MeSH Supplementary Concept]
- asparaginase [MeSH Descriptor]
- asparaginase erwinia chrysanthemi, recombinant-rywn [MeSH Supplementary Concept]
- asulacrine [MeSH Supplementary Concept]
- atezolizumab [MeSH Supplementary Concept]
- avarol [MeSH Supplementary Concept]
- azatoxin [MeSH Supplementary Concept]
- azelaic acid [MeSH Supplementary Concept]
- balofloxacin [MeSH Supplementary Concept]
- bastadin 14 [MeSH Supplementary Concept]
- batimastat [MeSH Supplementary Concept]
- belinostat [MeSH Supplementary Concept]
- belotecan [MeSH Supplementary Concept]
- benzyloxycarbonylleucyl-leucyl-leucine aldehyde [MeSH Supplementary Concept]
- besifloxacin [MeSH Supplementary Concept]
- bestrabucil [MeSH Supplementary Concept]
- beta-aspartylhydroxamic acid [MeSH Supplementary Concept]
- bicalutamide [MeSH Supplementary Concept]
- bimolane [MeSH Supplementary Concept]
- bis(helenalinyl)glutarate [MeSH Supplementary Concept]
- bis(isoalantodiol-B)glutarate [MeSH Supplementary Concept]
- bis-1,3-((5,6-dihydro-5,11-diketo-11H-indeno(1,2-c)isoquinoline)-6-propylamino)propane [MeSH Supplementary Concept]
- bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II) [MeSH Supplementary Concept]
- blinatumomab [MeSH Supplementary Concept]
- brequinar [MeSH Supplementary Concept]
- bropirimine [MeSH Supplementary Concept]
- bryostatin 1 [MeSH Supplementary Concept]
- bufalin [MeSH Supplementary Concept]
- calcein AM [MeSH Supplementary Concept]
- calpain inhibitors [MeSH Supplementary Concept]
- canertinib dihydrochloride [MeSH Supplementary Concept]
- carbobenzoxycoumarin [MeSH Supplementary Concept]
- carboplatin [MeSH Descriptor]
- carbopol 940 [MeSH Supplementary Concept]
- carboxyamido-triazole [MeSH Supplementary Concept]
- carboxyimamidate [MeSH Supplementary Concept]
- carmofur [MeSH Supplementary Concept]
- cauloside A [MeSH Supplementary Concept]
- cc-486 [MeSH Supplementary Concept]
- cecropin B protein, insecta [MeSH Supplementary Concept]
- cediranib [MeSH Supplementary Concept]
- ceritinib [MeSH Supplementary Concept]
- chebulagic acid [MeSH Supplementary Concept]
- chelerythrine [MeSH Supplementary Concept]
- chiauranib [MeSH Supplementary Concept]
- chlorobiocic acid [MeSH Supplementary Concept]
- chlorozotocin [MeSH Supplementary Concept]
- cicaprost [MeSH Supplementary Concept]
- cinoxacin [MeSH Descriptor]
- ciprofloxacin [MeSH Descriptor]
- cisplatin [MeSH Descriptor]
- cladribine [MeSH Descriptor]
- clinafloxacin [MeSH Supplementary Concept]
- clomesone [MeSH Supplementary Concept]
- copper bis(3,5-diisopropylsalicylate) [MeSH Supplementary Concept]
- cordycepin [MeSH Supplementary Concept]
- coumarins [MeSH Descriptor]
- coumermycin [MeSH Supplementary Concept]
- crenolanib [MeSH Supplementary Concept]
- curcumin [MeSH Descriptor]
- cyclocreatine [MeSH Supplementary Concept]
- cyclopentenyl cytosine [MeSH Supplementary Concept]
- cyclothialidine [MeSH Supplementary Concept]
- cyproterone acetate [MeSH Descriptor]
- dabrafenib [MeSH Supplementary Concept]
- dactolisib [MeSH Supplementary Concept]
- daratumumab [MeSH Supplementary Concept]
- demethylzeylasterone [MeSH Supplementary Concept]
- denileukin diftitox [MeSH Supplementary Concept]
- deuterium oxide [MeSH Descriptor]
- dexrazoxane [MeSH Descriptor]
- diacetoxyscirpenol [MeSH Supplementary Concept]
- diamminedichlorodihydroxyplatinum IV [MeSH Supplementary Concept]
- diaziquone [MeSH Supplementary Concept]
- dicentrinone [MeSH Supplementary Concept]
- dichloro-1,2-diaminocyclohexane platinum complex [MeSH Supplementary Concept]
- didemnins [MeSH Supplementary Concept]
- dihematoporphyrin ether [MeSH Descriptor]
- dinutuximab [MeSH Supplementary Concept]
- ditercalinium [MeSH Supplementary Concept]
- dl1520 [MeSH Supplementary Concept]
- dofequidar [MeSH Supplementary Concept]
- droloxifene [MeSH Supplementary Concept]
- edatrexate [MeSH Supplementary Concept]
- edelfosine [MeSH Supplementary Concept]
- efatutazone [MeSH Supplementary Concept]
- eflornithine [MeSH Descriptor]
- eleutherin [MeSH Supplementary Concept]
- ellipticine [MeSH Supplementary Concept]
- elliptinium [MeSH Supplementary Concept]
- elotuzumab [MeSH Supplementary Concept]
- enocitabine [MeSH Supplementary Concept]
- enoxacin [MeSH Descriptor]
- ensartinib [MeSH Supplementary Concept]
- entinostat [MeSH Supplementary Concept]
- epithalamin [MeSH Supplementary Concept]
- eryaspase [MeSH Supplementary Concept]
- etanidazole [MeSH Descriptor]
- ethiodized oil [MeSH Descriptor]
- ethoxidine [MeSH Supplementary Concept]
- ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid [MeSH Supplementary Concept]
- etirinotecan pegol [MeSH Supplementary Concept]
- etoposide phosphate [MeSH Supplementary Concept]
- exatecan [MeSH Supplementary Concept]
- exemestane [MeSH Supplementary Concept]
- farletuzumab [MeSH Supplementary Concept]
- farnesylthiosalicylic acid [MeSH Supplementary Concept]
- fazarabine [MeSH Supplementary Concept]
- felzartamab [MeSH Supplementary Concept]
- fiacitabine [MeSH Supplementary Concept]
- finafloxacin [MeSH Supplementary Concept]
- flavone acetic acid [MeSH Supplementary Concept]
- fleroxacin [MeSH Descriptor]
- fludarabine [MeSH Supplementary Concept]
- flumequine [MeSH Supplementary Concept]
- folfirinox [MeSH Supplementary Concept]
- formestane [MeSH Supplementary Concept]
- formycin [MeSH Supplementary Concept]
- fotemustine [MeSH Supplementary Concept]
- fucoidan [MeSH Supplementary Concept]
- futibatinib [MeSH Supplementary Concept]
- galiximab [MeSH Supplementary Concept]
- gallium nitrate [MeSH Supplementary Concept]
- garenoxacin [MeSH Supplementary Concept]
- geranylgeranylacetone [MeSH Supplementary Concept]
- ginsenoside Rb2 [MeSH Supplementary Concept]
- glycyl-arginyl-glycyl-aspartyl-serine [MeSH Supplementary Concept]
- gold colloid, radioactive [MeSH Descriptor]
- grepafloxacin [MeSH Supplementary Concept]
- guadecitabine [MeSH Supplementary Concept]
- guanazole [MeSH Descriptor]
- hematoporphyrin derivative [MeSH Descriptor]
- hexaamminecobalt(II) [MeSH Supplementary Concept]
- hexamethylene bisacetamide [MeSH Supplementary Concept]
- hydrazine [MeSH Supplementary Concept]
- hydroxyguanidine [MeSH Supplementary Concept]
- hydroxyurea [MeSH Descriptor]
- hypericin [MeSH Supplementary Concept]
- hypocrellin A [MeSH Supplementary Concept]
- idarubicinol [MeSH Supplementary Concept]
- idelalisib [MeSH Supplementary Concept]
- ilmofosine [MeSH Supplementary Concept]
- ilorasertib [MeSH Supplementary Concept]
- immunotoxin HA22 [MeSH Supplementary Concept]
- indolocarbazole derivative R-6 [MeSH Supplementary Concept]
- infigratinib [MeSH Supplementary Concept]
- interferon omega 1 [MeSH Supplementary Concept]
- interferon type i [MeSH Descriptor]
- interferon-alfa-1b [MeSH Supplementary Concept]
- interferon-beta [MeSH Descriptor]
- interferons [MeSH Descriptor]
- ipatasertib [MeSH Supplementary Concept]
- iproplatin [MeSH Supplementary Concept]
- iron(II)-ascorbic acid complex [MeSH Supplementary Concept]
- isoaurostatin [MeSH Supplementary Concept]
- isobutyramide [MeSH Supplementary Concept]
- isocamptothecin A [MeSH Supplementary Concept]
- isocamptothecin B [MeSH Supplementary Concept]
- isoindigotin [MeSH Supplementary Concept]
- isomurisolenin [MeSH Supplementary Concept]
- ivosidenib [MeSH Supplementary Concept]
- ixazomib [MeSH Supplementary Concept]
- jasplakinolide [MeSH Supplementary Concept]
- juglone [MeSH Supplementary Concept]
- juzentaihoto [MeSH Supplementary Concept]
- kalihinol F [MeSH Supplementary Concept]
- kibdelomycin A [MeSH Supplementary Concept]
- lanreotide [MeSH Supplementary Concept]
- lentinan [MeSH Descriptor]
- lenvatinib [MeSH Supplementary Concept]
- leptosin C [MeSH Supplementary Concept]
- leptosin F [MeSH Supplementary Concept]
- levan [MeSH Supplementary Concept]
- levofloxacin [MeSH Descriptor]
- lexitropsin [MeSH Supplementary Concept]
- lomefloxacin [MeSH Supplementary Concept]
- lonidamine [MeSH Supplementary Concept]
- losoxantrone [MeSH Supplementary Concept]
- lurtotecan [MeSH Supplementary Concept]
- lysyl-cysteinyl-cysteinyl-arginyl-cysteinyl-lysine [MeSH Supplementary Concept]
- mafosfamide [MeSH Supplementary Concept]
- makaluvamine H [MeSH Supplementary Concept]
- makaluvamine I [MeSH Supplementary Concept]
- makaluvamine N [MeSH Supplementary Concept]
- mapatumumab [MeSH Supplementary Concept]
- margetuximab [MeSH Supplementary Concept]
- matadine [MeSH Supplementary Concept]
- mepitiostane [MeSH Supplementary Concept]
- mequinol [MeSH Supplementary Concept]
- merbarone [MeSH Supplementary Concept]
- methanol extraction residue (MER) tubercle bacillus fraction [MeSH Supplementary Concept]
- methyl 2,5-dihydroxycinnamate [MeSH Supplementary Concept]
- methyl 3-(4-(bis(2-chloroethyl)amino)phenyl)-2-(2-(4-((N-isopropyl)amidino)phenyl)furan-5-carboxamido)propanoate [MeSH Supplementary Concept]
- methylformamide [MeSH Supplementary Concept]
- metoprine [MeSH Supplementary Concept]
- midostaurin [MeSH Supplementary Concept]
- miltefosine [MeSH Supplementary Concept]
- misonidazole [MeSH Descriptor]
- mitoguazone [MeSH Descriptor]
- mitonafide [MeSH Supplementary Concept]
- mitopodozide [MeSH Supplementary Concept]
- mitoxantrone [MeSH Descriptor]
- mitozolomide [MeSH Supplementary Concept]
- mofarotene [MeSH Supplementary Concept]
- mogamulizumab [MeSH Supplementary Concept]
- molgramostim [MeSH Supplementary Concept]
- monoclonal antibody YYB-101 [MeSH Supplementary Concept]
- monodansylcadaverine [MeSH Supplementary Concept]
- mopidamol [MeSH Descriptor]
- morelensin [MeSH Supplementary Concept]
- motexafin gadolinium [MeSH Supplementary Concept]
- musk ketone [MeSH Supplementary Concept]
- nadifloxacin [MeSH Supplementary Concept]
- nafazatrom [MeSH Supplementary Concept]
- nalidixic acid [MeSH Descriptor]
- naphthazarin [MeSH Supplementary Concept]
- naquotinib [MeSH Supplementary Concept]
- nartograstim [MeSH Supplementary Concept]
- navitoclax [MeSH Supplementary Concept]
- nazartinib [MeSH Supplementary Concept]
- nebularine [MeSH Supplementary Concept]
- nedaplatin [MeSH Supplementary Concept]
- neocryptolepine [MeSH Supplementary Concept]
- neocuproine [MeSH Supplementary Concept]
- nickel carbonyl [MeSH Supplementary Concept]
- niguldipine [MeSH Supplementary Concept]
- nilutamide [MeSH Supplementary Concept]
- nimustine [MeSH Descriptor]
- nintedanib [MeSH Supplementary Concept]
- nitracrine [MeSH Descriptor]
- norcantharidin [MeSH Supplementary Concept]
- norfloxacin [MeSH Descriptor]
- norindenoisoquinoline [MeSH Supplementary Concept]
- novobiocin 401 [MeSH Supplementary Concept]
- oblimersen [MeSH Supplementary Concept]
- ofatumumab [MeSH Supplementary Concept]
- ofloxacin [MeSH Descriptor]
- olaratumab [MeSH Supplementary Concept]
- onapristone [MeSH Supplementary Concept]
- oncostatin M [MeSH Descriptor]
- oprelvekin [MeSH Supplementary Concept]
- ormaplatin [MeSH Supplementary Concept]
- osimertinib [MeSH Supplementary Concept]
- oxolinic acid [MeSH Descriptor]
- paclitaxel poliglumex [MeSH Supplementary Concept]
- palbociclib [MeSH Supplementary Concept]
- pazufloxacin [MeSH Supplementary Concept]
- pefloxacin [MeSH Descriptor]
- pegaspargase [MeSH Supplementary Concept]
- penclomedine [MeSH Supplementary Concept]
- pentamethylmelamine [MeSH Supplementary Concept]
- pentostatin [MeSH Descriptor]
- perillyl alcohol [MeSH Supplementary Concept]
- picibanil [MeSH Descriptor]
- picrosteganol [MeSH Supplementary Concept]
- pirarubicin [MeSH Supplementary Concept]
- pirfenidone [MeSH Supplementary Concept]
- piritrexim [MeSH Supplementary Concept]
- pirlindole [MeSH Supplementary Concept]
- piroxantrone [MeSH Supplementary Concept]
- pixantrone [MeSH Supplementary Concept]
- platinum ethylenediamine dichloride [MeSH Supplementary Concept]
- plomestane [MeSH Supplementary Concept]
- poly(maleic acid-styrene)neocarzinostatin [MeSH Supplementary Concept]
- ponatinib [MeSH Supplementary Concept]
- pralsetinib [MeSH Supplementary Concept]
- procarbazine [MeSH Descriptor]
- prolinedithiocarbamate [MeSH Supplementary Concept]
- propagermanium [MeSH Supplementary Concept]
- prospidium [MeSH Descriptor]
- prulifloxacin [MeSH Supplementary Concept]
- pulrodemstat besilate [MeSH Supplementary Concept]
- pyran copolymer [MeSH Descriptor]
- pyroglutamyl-histidyl-glycine [MeSH Supplementary Concept]
- quinacrine [MeSH Descriptor]
- radium ra 223 dichloride [MeSH Supplementary Concept]
- ranimustine [MeSH Supplementary Concept]
- ranpirnase [MeSH Supplementary Concept]
- ravoxertinib [MeSH Supplementary Concept]
- rebastinib [MeSH Supplementary Concept]
- retinamide [MeSH Supplementary Concept]
- rhodamine 6G [MeSH Supplementary Concept]
- ribonuclease SPL [MeSH Supplementary Concept]
- ricolinostat [MeSH Supplementary Concept]
- ridostin [MeSH Supplementary Concept]
- ritrosulfan [MeSH Supplementary Concept]
- ro 23-7553 [MeSH Supplementary Concept]
- ro 47-3359 [MeSH Supplementary Concept]
- ropidoxuridine [MeSH Supplementary Concept]
- rosettacin [MeSH Supplementary Concept]
- rubitecan [MeSH Supplementary Concept]
- rufloxacin [MeSH Supplementary Concept]
- ruthenium ben [MeSH Supplementary Concept]
- ruthenium sal [MeSH Supplementary Concept]
- safranine T [MeSH Supplementary Concept]
- sagopilone [MeSH Supplementary Concept]
- salvianolic acid A [MeSH Supplementary Concept]
- sapacitabine [MeSH Supplementary Concept]
- saracatinib [MeSH Supplementary Concept]
- sarcophytol A [MeSH Supplementary Concept]
- satraplatin [MeSH Supplementary Concept]
- schizandrin B [MeSH Supplementary Concept]
- selenazofurin [MeSH Supplementary Concept]
- seocalcitol [MeSH Supplementary Concept]
- seviteronel [MeSH Supplementary Concept]
- siltuximab [MeSH Supplementary Concept]
- sitafloxacin [MeSH Supplementary Concept]
- soblidotin [MeSH Supplementary Concept]
- sobuzoxane [MeSH Supplementary Concept]
- sparfloxacin [MeSH Supplementary Concept]
- specific substance maruyama [MeSH Supplementary Concept]
- spirogermanium [MeSH Supplementary Concept]
- spiroplatin [MeSH Supplementary Concept]
- streptococcal polysaccharide type III group B [MeSH Supplementary Concept]
- sulfoquinovosyl diglyceride [MeSH Supplementary Concept]
- sulindac [MeSH Descriptor]
- sulindac sulfide [MeSH Supplementary Concept]
- sulofenur [MeSH Supplementary Concept]
- suramin [MeSH Descriptor]
- tacedinaline [MeSH Supplementary Concept]
- talactoferrin alfa [MeSH Supplementary Concept]
- taurolidine [MeSH Supplementary Concept]
- taxane [MeSH Supplementary Concept]
- temafloxacin [MeSH Supplementary Concept]
- temoporfin [MeSH Supplementary Concept]
- teniposide [MeSH Descriptor]
- tepotinib [MeSH Supplementary Concept]
- teroxirone [MeSH Supplementary Concept]
- tetraphenylphosphonium [MeSH Supplementary Concept]
- tezacitabine [MeSH Supplementary Concept]
- thiazolidine-4-carboxylic acid [MeSH Supplementary Concept]
- thymidine 5'-diphosphate [MeSH Supplementary Concept]
- tilorone [MeSH Descriptor]
- tipifarnib [MeSH Supplementary Concept]
- titanocene dichloride [MeSH Supplementary Concept]
- topopyrone A [MeSH Supplementary Concept]
- topopyrone B [MeSH Supplementary Concept]
- topopyrone C [MeSH Supplementary Concept]
- topopyrone D [MeSH Supplementary Concept]
- topostatin [MeSH Supplementary Concept]
- topostin A1 [MeSH Supplementary Concept]
- topostin A2 [MeSH Supplementary Concept]
- topostin B [MeSH Supplementary Concept]
- topotecan [MeSH Descriptor]
- tositumomab I-131 [MeSH Supplementary Concept]
- trabedersen [MeSH Supplementary Concept]
- trametinib [MeSH Supplementary Concept]
- trastuzumab biosimilar HLX02 [MeSH Supplementary Concept]
- tremelimumab [MeSH Supplementary Concept]
- tretazicar [MeSH Supplementary Concept]
- tretinoin [MeSH Descriptor]
- triazinate [MeSH Supplementary Concept]
- tricyclodecane-9-yl-xanthogenate [MeSH Supplementary Concept]
- tridemethyl-N-(4'-nitrobenzoyl)deacetylthiocolchicine [MeSH Supplementary Concept]
- trilostane [MeSH Supplementary Concept]
- trovafloxacin [MeSH Supplementary Concept]
- troxacitabine [MeSH Supplementary Concept]
- tryptophyl-tyrosyl-cysteinyl-arginyl-cysteinyl-lysine [MeSH Supplementary Concept]
- tubulazole [MeSH Supplementary Concept]
- tucatinib [MeSH Supplementary Concept]
- tyrosyl-isoleucyl-glycyl-seryl-arginine [MeSH Supplementary Concept]
- tyrphostin 25 [MeSH Supplementary Concept]
- tyrphostin A23 [MeSH Supplementary Concept]
- tyrphostins [MeSH Descriptor]
- ukrain [MeSH Supplementary Concept]
- ulifloxacin [MeSH Supplementary Concept]
- urethane [MeSH Descriptor]
- vadimezan [MeSH Supplementary Concept]
- valrubicin [MeSH Supplementary Concept]
- vapreotide [MeSH Supplementary Concept]
- veltuzumab [MeSH Supplementary Concept]
- venetoclax [MeSH Supplementary Concept]
- vesnarinone [MeSH Supplementary Concept]
- viscum album peptide [MeSH Supplementary Concept]
- vorozole [MeSH Supplementary Concept]
- voruciclib [MeSH Supplementary Concept]
- zanubrutinib [MeSH Supplementary Concept]
- zilascorb [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anticancer agents [ICD-11 Extension code]
- Antineoplastic Agent [NCIt concept]
- Antineoplastic agent (substance) [SNOMED CT concept]
- Medicinal product acting as antineoplastic agent (product) [SNOMED CT concept]
- antineoplastic agent, nos [SNOMED Notion]
- antineoplastic agents [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients